Titan Medical Stock

Titan Medical ROCE 2024

Titan Medical ROCE

1.87

Ticker

TMD.TO

ISIN

CA88830X8199

WKN

A2JN66

In 2024, Titan Medical's return on capital employed (ROCE) was 1.87, a -86.78% increase from the 14.15 ROCE in the previous year.

Titan Medical Aktienanalyse

What does Titan Medical do?

Titan Medical Inc is a company specialized in the development of robotic systems for minimally invasive procedures in the field of medicine. It was founded in 2008 in Toronto, Canada by Reiza Rayman and Dmitry Oleynikov. The main goal of Titan Medical was to revolutionize surgery by developing innovative systems that enable more precise, less invasive, and more effective medical treatments. The business model of Titan Medical is based on the development, manufacturing, and marketing of robotic systems for minimally invasive surgical procedures. The main area of focus for Titan Medical is the development and distribution of robotic systems for urological, gynecological, and endoscopic surgery. These systems contribute to improving patient treatment and speeding up recovery by operating more precisely and safely than traditional surgical methods. The flagship product of Titan Medical is the Sport-Surgery System (STS), specifically designed for sports medicine, orthopedics, and spinal surgery. The STS technology provides an enhanced view of the surgical field, reducing the risk of injuries and complications. The STS system by Titan Medical is unique and stands out for its wireless operation, compatibility with conventional instruments, and ability to integrate different imaging modalities. Another product offered by Titan Medical is the Single-Port version of the Sport-Surgery System. This system is the first robotic system capable of performing minimally invasive surgery through a single incision. The system offers faster recovery, reduces scarring, and potential complications. The Single-Port version by Titan Medical is a unique product in the market and has the potential to revolutionize the practice of minimally invasive surgery. Titan Medical operates research and development departments in Toronto, Canada, and Chapel Hill, North Carolina, USA. These departments work on the development of new technologies aimed at improving surgery and enhancing patients' quality of life. The company collaborates with universities and clinics to test and validate innovative technologies. Titan Medical aims to market its products worldwide. The company works with distribution partners and distributors in North America, Europe, Asia, and Australia to place its products in different markets. Titan Medical places particular emphasis on training and supporting its customers to ensure the maximum efficiency and effectiveness of its products. In 2014, Titan Medical went public and has been listed on the Toronto Stock Exchange and NASDAQ since then. The company has experienced strong growth in recent years and has become an innovative leader in robotic surgery. Titan Medical has received numerous awards and recognition for its innovative products and technologies, including the Innovation Technology Award and the Medical Device Excellence Award. Overall, Titan Medical is a company specialized in the development of robotic systems for minimally invasive surgery. The company aims to make surgical procedures safer and more precise while speeding up patient recovery. By collaborating with universities and clinics, Titan Medical continuously works on developing new technologies and products to push the boundaries of minimally invasive surgery and improve patient care. Titan Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Titan Medical's Return on Capital Employed (ROCE)

Titan Medical's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Titan Medical's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Titan Medical's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Titan Medical’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Titan Medical stock

What is the ROCE (Return on Capital Employed) of Titan Medical this year?

The ROCE of Titan Medical is 1.87 undefined this year.

How has the ROCE (Return on Capital Employed) of Titan Medical developed compared to the previous year?

The ROCE of Titan Medical has increased by -86.78% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Titan Medical?

A high Return on Capital Employed (ROCE) indicates that Titan Medical has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Titan Medical?

A low ROCE (Return on Capital Employed) can indicate that Titan Medical has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Titan Medical impact the company?

An increase in the ROCE of Titan Medical can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Titan Medical affect the company?

A decrease in ROCE of Titan Medical can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Titan Medical?

Some factors that can affect Titan Medical's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Titan Medical so important for investors?

The ROCE of Titan Medical is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Titan Medical take to improve the ROCE?

To improve the ROCE, Titan Medical can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Titan Medical pay?

Over the past 12 months, Titan Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Titan Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Titan Medical?

The current dividend yield of Titan Medical is .

When does Titan Medical pay dividends?

Titan Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Titan Medical?

Titan Medical paid dividends every year for the past 0 years.

What is the dividend of Titan Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Titan Medical located?

Titan Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Titan Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Titan Medical from 7/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/11/2024.

When did Titan Medical pay the last dividend?

The last dividend was paid out on 7/11/2024.

What was the dividend of Titan Medical in the year 2023?

In the year 2023, Titan Medical distributed 0 USD as dividends.

In which currency does Titan Medical pay out the dividend?

The dividends of Titan Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Titan Medical

Our stock analysis for Titan Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Titan Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.